Thailand The top ten companies in the USD 6.9 billion Thai pharma market for 2021 ranked by market share, compiled by Thai banking firm Krungsti. Three of the featured firms – Mega Lifesciences, Better Pharma, and Berlin Pharma – are locals, while multinationals of the likes of AstraZeneca, Pfizer, and Novartis…
Thailand Thailand was the world’s fourth-largest medical tourism destination in 2017, with a market value of around USD 600 million. Made with Visme Infographic Maker
Thailand Thailand’s medical devices (medtech) market is projected to grow from USD 1.2 billion in 2016 to 1.7 billion in 2020, representing a CAGR of 8.1%. Made with Visme Infographic Maker
Thailand The Thai pharma market, one of the largest in the ASEAN region, stood at USD 4.6 billion in size in 2016. A recent report from the Dutch Embassy in Thailand projects that the market will grow to USD 6.3 billion in 2021 and 8.4 billion by 2026. Made with Visme…
Thailand Thailand’s healthcare expenditure is projected to rise from USD 25.3 billion in 2016 to 47.9 billion by 2026, a ten-year CAGR of 6.6%. Made with Visme Infographic Maker According to a 2018 report from the Dutch Embassy in Thailand, in 2018 Thailand had around 50,000 physicians and 25,000 health…
Thailand The top 10 pharmaceutical companies in Thailand for 2018 ranked by revenues. Global giants Pfizer, GSK and MSD make up the top three of a list dominated by Big Pharma. Siam Bioscience and Berlin Pharm are the sole Thai representatives on the list. Berlin Pharm and Takeda are the companies…
Thailand Click here to read more articles and interviews from Thailand, and to download the latest free pharma report on the country.
See our Cookie Privacy Policy Here
